Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Update Il y a 4 ans
Reference: NCT01075178

Woman and Man

Extract

Retrospective medical record review study of specific adverse events in children with congenital heart disease who received palivizumab for prophylaxis of serious respiratory syncytial virus infection and control subjects that did not receive palivizumab


Inclusion criteria

  • Severe Respiratory Syncytial Virus Infection


Links